Document Type
Article
Publication Date
1-2018
Publication Source
Endoscopy International Open
Abstract
Background/aims: In an investigator-initiated, prospective study, we evaluated the feasibility of a five-gene sequence point-of-care (POC) testing strategy (Xpert CARBA-R Assay, Cepheid Inc., Sunnyvale, CA, USA), compared to reference laboratory PCR (48 – 72 hours turnaround time, two gene sequences), in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) and in a hospital outbreak investigation.
Methods: After informed consent, patients undergoing ERCP (September 2015 – April 2016, n = 191) at Mayo Clinic and potential hospital contacts (n = 9) of an index carbapenem-resistant organism (CRO)-positive inpatient were included. Two rectal swabs, one each for reference and POC assays were obtained. The Xpert CARBA-R Assay enables qualitative rapid detection of five beta-lactamase gene sequences associated with carbapenem-non-susceptibility in Gram-negative bacteria. Feasibility parameters (specimen processing and assay run time, ease of use) and percent agreement between the tests were calculated using JMP Pro11 (SAS Corp, Cary, NC, USA).
Results: Mean age was 62 ± 15 years; 108 (54 %) were male. Both tests were successfully performed in all patients. The POC test was rated by endoscopy nurses as easy/very easy to conduct in 193 patients (97 %); median assay run time and median time for specimen collection and processing were 55 minutes (interquartile range IQR: 53 – 55 minutes) and 3 minutes (IQR: 3 – 6 minutes), respectively. In 200/201 (99.5 %) tests, there was agreement between the POC and reference PCR.
Conclusions: The more comprehensive POC CRO testing of patients in the endoscopy suite is feasible and results are available in < 1 hour. This strategy may enable rapid risk stratification of duodenoscope exposure to CRO and potentially improve operational efficiency and decrease costs.
Inclusive pages
E58–E63
ISBN/ISSN
Print: 2364-3722; Electronic: 2196-9736
Document Version
Published Version
Copyright
© 2023 Georg Thieme Verlag KG
Publisher
Thieme
Volume
6
Peer Reviewed
yes
Issue
1
eCommons Citation
Pannala, Rahul; Baldwin, Bruce; Aluru, Vijay; Grys, Thomas E.; Holmes, Jordan; Miller, Laurence J.; Harrison, M. Edwyn; Nguyen, Cuong C.; Tenover, Fred C.; Persing, David; and Faigel, Douglas O., "Prospective study of the feasibility of point-of-care testing strategy for carbapenem-resistant organism detection" (2018). Biology Faculty Publications. 332.
https://ecommons.udayton.edu/bio_fac_pub/332
COinS
Comments
The document is made available in compliance with the publisher's open-access policy, licensed under the Creative Commons CC BY-NC-ND 4.0 license. DOI: 10.1055/s-0043-122141